PDB17 TOTAL Cost of Care and Utilization Among Medicare Fee-for-Service (FFS) Patients with Metastatic Pancreatic Cancer Treated with FDA-Approved/NCCN® Category 1 Regimens at 340B VS. NON-340B Hospitals

Saved in:
Bibliographic Details
Published in:Value in health 2021-06, Vol.24, p.S80-S81
Main Authors: Tomicki, S., Latimer, H., Dieguez, G., Cockrum, P., Kim, G.P.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2021.04.415